Surgisistrade mark mesh: a novel approach to repair of a recurrent rectovaginal fistula.
This study was designed to repair a recurrent rectovaginal fistula using a new surgical approach that incorporates a Surgisistrade mark mesh. A 63-year-old female with a history of recurrent rectovaginal fistula, which was treated originally by a traditional mucosal advancement flap technique, underwent a surgical procedure in which a biocompatible mesh was incorporated into the repair. The patient was symptom-free one-year after the procedure. Surgery for recurrent rectovaginal fistula incorporating a Surgisistrade mark mesh can be used as an innovative option.